Genetics Generation Advancement (4160.TWO) Action Cours

Genetics Generation Advancement Corp. generates revenue through genetic testing, molecular diagnostics, biotechnology services, and personalized health-related testing. The company serves maternal-fetal precision, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precision health management segments. Its domestic and overseas markets purchase these services, with clients including healthcare providers and individuals seeking personalized medical insights. The firm's offerings are tailored to specific health management needs across these segments. The business provides biological information services and health care services as part of its core offerings. These services are delivered to both domestic and international clients, focusing on precision health management and diagnostic solutions. The company's revenue streams are derived from the provision of these specialized services, targeting healthcare institutions and individual consumers in the health and biotechnology sectors. Genetics Generation Advancement Corp. operates in the genetic testing and biotechnology sectors, delivering molecular diagnostics and health care services. Its primary customers are healthcare providers and individuals requiring personalized medical testing. The firm's services are designed to support precision health management and diagnostic needs, with a focus on maternal-fetal, pediatric, and cancer-related health applications.